Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1
about
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1
description
im Mai 2020 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 27 May 2020
@en
name
Early administration of imatin ...... el of neurofibromatosis type 1
@en
type
label
Early administration of imatin ...... el of neurofibromatosis type 1
@en
prefLabel
Early administration of imatin ...... el of neurofibromatosis type 1
@en
P2093
P356
P1476
Early administration of imatin ...... el of neurofibromatosis type 1
@en
P2093
Abbi Smith
D Wade Clapp
David A Ingram
Feng-Chun Yang
Jaishri O Blakeley
Kent A Robertson
Michael J Ferguson
P304
P356
10.1002/PBC.28372
P577
2020-05-27T00:00:00Z